Please assess the completion status of the following clinical trial:

Trial Title: Celiac Plexus Block for Chronic Pancreatitis RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Presentation with upper abdominal pain suggestive of pancreatitis who are undergoing EUS for evaluation~* M ANNHEIM severity index of 6 or greater to be included~* Intermittent episodes of pain\>3 requiring opiate medication~Exclusion Criteria:~* Patients who have allergic reactions to steroids or bupivacaine~* INR \>1.6~* platelets \<75~* decompensated cirrhosis~* incarcerated~* \<18 years old~* unable to give informed consent~* peptic ulcer disease~* ongoing substance or alcohol use

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EUS with Celiac Block (Type: EXPERIMENTAL): Celiac Block with triamcinolone and bupivicaine Intra Plexus Triamcinolone and Bupivicaine Injection
- EUS without Celiac Block (Type: ACTIVE_COMPARATOR): Patients will undergo EUS but no celiac block will be performed

Based on this trial design, predict the completion outcome and termination type (if applicable).